Profil
David F.
Paolella founded Ajinomoto Cambrooke, Inc. in 2000, where he is working as Director from 2000.
Mr. Paolella also founded Tandem Biotherapeutics, Inc., where he worked as Chief Executive Officer.
Postes actifs de David F. Paolella
| Sociétés | Poste | Début |
|---|---|---|
Ajinomoto Cambrooke, Inc.
 Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA. | Fondateur | 09/03/2011 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Ajinomoto Cambrooke, Inc.
Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA. | Health Technology |
